VCYT
Veracyte, Inc.
Stock
$45.81+1.62 (+3.67%)Close Oct 2, 2026
- Capital expenditures, 2025
- $9.7M
- YoY, 2025
- −14.3%
- 5-year CAGR
- +27.8%
- 10-year CAGR
- +4.6%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $9.7M | −14.3% |
| 2024 | $11M | +13.3% |
| 2023 | $10.0M | +16.5% |
| 2022 | $8.5M | +59.0% |
| 2021 | $5.4M | +89.5% |
| 2020 | $2.8M | +2.9% |
| 2019 | $2.8M | +47.1% |
| 2018 | $1.9M | +6.8% |
| 2017 | $1.8M | −58.3% |
| 2016 | $4.2M | −31.7% |
| 2015 | $6.2M | +204.6% |
| 2014 | $2.0M | +52.0% |
| 2013 | $1.3M | −8.9% |
| 2012 | $1.5M | +429.7% |
| 2011 | $276K | — |